1210 Initiation of Methadone for Refractory Restless Leg Syndrome with Significant Improvement of Symptoms

Carla Damia,Brittany Monceaux,Catherine Hall,Paul Bhamrah,Rupa Koothirezhi,Cesar Liendo,Minh Tam Ho,Naomi Ghildiyal,Oleg Chernyshev

DOI: https://doi.org/10.1093/sleep/zsae067.01210

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Restless legs syndrome (RLS) is a common sleep-related movement disorder. We are reporting a case of progressive and refractory RLS in which a patient had a long history of poorly controlled and worsening RLS with intolerance to first line medications and incomplete management of symptoms. Report of case(s) Patient is a 62-year-old Caucasian female with a past medical history of RLS, mild obstructive sleep apnea (diagnosed 2021), insomnia (managed with zolpidem), atrial fibrillation, coronary artery disease, obesity, diabetes, hypertension and osteoarthritis. Initial presentation to our clinic was 2 years ago. She reported RLS symptoms 20 years prior with treatment initiated 15 years ago. Symptoms started to worsen 5-6 years ago. She reported sensations in the upper extremities and symptoms starting earlier in the day. She noted intolerance, side effects to and ineffectiveness of first-line medications. Pregabalin produced oral blisters and gabapentin sedated her with minimal benefit to leg sensations. She was on ropinirole 0.25mg in the AM and 2mg in the evening. Dosage was increased but patient found that increased dosage during the day caused sedation and did not alleviate symptoms. Ferritin was low and patient had been on oral iron without change in symptoms. Iron infusion was recommended but deemed not feasible. After the first visit, patient presented 3 months later. She had required an emergency cholecystectomy and was given hydromorphone and morphine while hospitalized. These medications completely alleviated symptoms for several days. Patient had taken other opioid medications including tramadol, hydrocodone and oxycodone in the past without any effect on symptoms. Patient was continued on ropinirole 2mg at night and started on methadone 5mg daily. She has noted a significant improvement in symptoms with almost complete alleviation. She denies any side effects from this regimen and has been stable on this regimen for almost 2 years without worsening symptoms. Conclusion This case focuses on the benefit of specific opioids for management of refractory RLS. Initial selection of an opioid may not produce benefit but evaluating response to different medications and tailoring a treatment plan for each individual patient could produce notable alleviation of debilitating symptoms that occur with progressive and refractory RLS. Support (if any)

neurosciences,clinical neurology